Penetration of piperacillin into cardiac valves, subcutaneous and muscle tissue of patients undergoing open-heart surgery

1982 ◽  
Vol 9 (6) ◽  
pp. 489-492 ◽  
Author(s):  
F. D. Daschner ◽  
M. Just ◽  
G. Spillner ◽  
V. Schlosser
1985 ◽  
Vol 19 (1) ◽  
pp. 49-53 ◽  
Author(s):  
Rolf Pieper ◽  
Axel Henze ◽  
Kenneth Josefsson ◽  
Lennart Magni ◽  
Carl Erik Nord

1984 ◽  
Vol 14 (4) ◽  
pp. 431-434 ◽  
Author(s):  
H.-M. Just ◽  
M. Bassler ◽  
U. Frank ◽  
G. Spillner ◽  
V. Schlosser ◽  
...  

1987 ◽  
Vol 31 (5) ◽  
pp. 813-814 ◽  
Author(s):  
U Frank ◽  
I Kappstein ◽  
E Schmidt-Eisenlohr ◽  
V Schlosser ◽  
G Spillner ◽  
...  

2011 ◽  
Vol 23 (01) ◽  
pp. 63-74
Author(s):  
Gideon Praveen Kumar ◽  
Lazar Mathew

Recently, percutaneous valve replacement has emerged as an alternative treatment for stenosis of mitral, aortic, and pulmonary valves, replacing the surgical approach and providing a new perspective on transcatheter placement of cardiac valves. The conventional open heart surgery does not suit most of the cardiothoracic patient population for various reasons. Percutaneous valve replacement has started becoming the first choice for surgical replacement of the cardiac valves. Under such a scenario where good potent porcine valves made from the pericardium of pigs are being made available, the real question is designing and developing cost effective stents to bear these valves. The ones that are imported are highly expensive which cannot be afforded by some of the Indian population. This also has substantial benefits from the standpoints of health, safety, and cost. The manufacturing of a stented aortic valve is an absolutely critical job, which requires proper designs, finite element analysis, and flow dynamics studies. This paper forms the base for an eventual manufacture of stented aortic valves, giving in-depth details pertaining to design and implantation of the bioprosthesis in the aorta with flow pattern analysis postimplantation and its hemodynamic efficacy analysis. Blood flow analysis and associated hemodynamic analysis help to understand the leakage resistance of the stented valve. A valve of this kind will enable minimal invasive cardiac surgeons to perform percutaneous aortic valve replacement with ease. This would also be an economic procedure allaying the high costs that are typically involved in conventional open heart surgery. We believe that this model has great potential for helping to set up a protocol for the growing of a tissue engineered heart valve construct.


1978 ◽  
Vol 39 (02) ◽  
pp. 474-487 ◽  
Author(s):  
E R Cole ◽  
F Bachmann ◽  
C A Curry ◽  
D Roby

SummaryA prospective study in 13 patients undergoing open-heart surgery with extracorporeal circulation revealed a marked decrease of the mean one-stage prothrombin time activity from 88% to 54% (p <0.005) but lesser decreases of factors I, II, V, VII and X. This apparent discrepancy was due to the appearance of an inhibitor of the extrinsic coagulation system, termed PEC (Protein after Extracorporeal Circulation). The mean plasma PEC level rose from 0.05 U/ml pre-surgery to 0.65 U/ml post-surgery (p <0.0005), and was accompanied by the appearance of additional proteins as evidenced by disc polyacrylamide gel electrophoresis of plasma fractions (p <0.0005). The observed increases of PEC, appearance of abnormal protein bands and concomitant increases of LDH and SGOT suggest that the release of an inhibitor of the coagulation system (similar or identical to PIVKA) may be due to hypoxic liver damage during extracorporeal circulation.


1967 ◽  
Vol 18 (03/04) ◽  
pp. 634-646 ◽  
Author(s):  
N Thurnherr

SummaryBlood clotting investigations have been executed in 25 patients who have undergone open heart surgery with extracorporeal circulation. A description of alterations in the activity of blood clotting factors, the fibrinolytic system, prothrombin consumption and platelets during several phases of the operation is given.


Sign in / Sign up

Export Citation Format

Share Document